SCHEMBL13319672

SCHEMBL13319672

Cc1ccccc1-c1c2ccc(-n3c4ccccc4c4ccccc43)cc2c(-c2ccccc2C)c2ccc(-n3c4ccccc4c4ccccc43)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ALKBH5 Q6P6C2 1/20 0.37
FTO Q9C0B1 1/20 0.37
BRD4 O60885 1/20 0.34
NTRK1 P04629 1/20 0.34
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GPR3 P46089 1/20 0.33
CDC7 O00311 1/20 0.33
EEF2K O00418 1/20 0.33
DAPK3 O43293 1/20 0.33
MAP4K4 O95819 1/20 0.33
PAK4 O96013 1/20 0.33
RPS6KB1 P23443 1/20 0.33
MARK3 P27448 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13428060 0.92 CDC7 (0.38) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL13428010 0.87 NR3C1 (0.37) KDM4EATML3MBTL1ALDH1A1GAA
SCHEMBL13427926 0.87 KDM4E (0.40) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL7603775 0.84 KDM4E (0.47) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL13319949 0.84 NR3C1 (0.41) KDM4EATMALDH1A1TP53GAA
SCHEMBL10098593 0.84 KDM4E (0.43) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL13319752 0.83 DNMT1 (0.36) L3MBTL1ALDH1A1NR3C1PGR
SCHEMBL13319709 0.82 NR3C1 (0.32) KDM4EALDH1A1TP53GAAHPGD
SCHEMBL19054953 0.82 KDM4E (0.47) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL22062923 0.82 KDM4E (0.47) KDM4EATML3MBTL1ALKBH5FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299703-B2 Blue light emitting compound and organic light emitting diode device comprising the same LG DISPLAY CO., LTD. (KR) 2012-10-30 US disclosed
US-8299703-B2 Blue light emitting compound and organic light emitting diode device comprising the same LG DISPLAY CO., LTD. (KR) 2012-10-30 US disclosed
US-20100140603-A1 BLUE LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE COMPRISING THE SAME LG. DISPLAY CO. LTD. (KR) 2010-06-10 US disclosed
US-20100140603-A1 BLUE LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE COMPRISING THE SAME LG. DISPLAY CO. LTD. (KR) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100140603-A1 BLUE LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE COMPRISING THE SAME CRY1, CRY2, CYBA KDM4E 3622/4885ATM 3143/4885L3MBTL1 146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.